Antithrombotic and thrombosis-eliminating preparation

Abstract

The invention relates to an antithrombotic and thrombosis-eliminating preparation, which is characterized by being prepared from the following raw material medicines in part by weight: 30 to 60 parts of astragalus, 3 to 6 parts of leech, 10 to 20 parts of safflower, 10 to 20 parts of red paeony root, 5 to 15 parts of root of red-rooted salvia and 10 to 20 parts of peach kernel. Compared with the prior art, the antithrombotic and thrombosis-eliminating preparation has the advantages that: based on the acute phase formation characteristics and pathological change of ishemic stroke, a compound Chinese medicine with effects of scattering and eliminating stasis, promoting dieresis and diminishing swelling is used to treat acute ishemic stroke; and lots of clinic tests prove that the antithrombotic and thrombosis-eliminating preparation has obvious treatment effects of preventing blood clotting, dissolving blood clots, expanding blood capillaries, relieving arteriospasm, lowering blood viscosity, improving flowing speed of microcirculating blood.

Description

technical field [0001] The invention relates to an antithrombotic and antithrombotic preparation for treating stroke. Background technique [0002] Stroke is also called stroke, which is divided into ischemic stroke and hemorrhagic stroke. Stroke is a general term for acute cerebrovascular diseases in traditional Chinese medicine. At present, the incidence of stroke is increasing year by year with the change of environment and diet structure, and the disability and death rate is quite high, which brings burden and economic loss to the family and society. Therefore, the research and treatment of stroke is a topic of general concern in the medical field. In the acute stage of ischemic stroke, thrombolytic therapy can generally be performed within 3 hours, but most patients have already missed the thrombolytic time when they come to the hospital, and can only be treated with calcium ion antagonists and brain protective agents to prevent platelet aggregation. The effect is ofte...

AI Technical Summary

Problems solved by technology

In the acute stage of ischemic stroke, thrombolytic therapy can generally be performed within 3 hours, but most patients have already missed the thrombolytic time when they come to the hospital, and can only be treated with calcium ion antagonists and brain protective agents to prevent platelet aggregation. The effect is often unsatisfactory. At present, the commonly used thrombolytic drugs include rt-PA or urokinase, which have relatively large side effects and easily cause vascular bleeding.

Images